» Articles » PMID: 11851337

The Crystal Structure of Human MRP14 (S100A9), a Ca(2+)-dependent Regulator Protein in Inflammatory Process

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2002 Feb 20
PMID 11851337
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Human MRP14 (hMRP14) is a Ca(2+)-binding protein from the S100 family of proteins. This protein is co-expressed with human MRP8 (hMRP8), a homologue protein in myeloid cells, and plays an indispensable role in Ca(2+)-dependent functions during inflammation. This role includes the activation of Mac-1, the beta(2) integrin which is involved in neutrophil adhesion to endothelial cells. The crystal structure of the holo form of hMRP14 was analyzed at 2.1 A resolution. hMRP14 is distinguished from other S100 member proteins by its long C-terminal region, and its structure shows that the region is extensively flexible. In this crystal structure of hMRP14, Chaps molecules bind to the hinge region that connects two EF-hand motifs, which suggests that this region is a target-binding site of this protein. Based on a structural comparison of hMRP14 with hMRP8 and human S100A12 (hS100A12) that is another homologue protein, the character of MRP8/14 hetero-complex and the functional significance of the flexibility of the C-terminal region of hMRP14 are discussed.

Citing Articles

Identification of regulator gene and pathway in myocardial ischemia-reperfusion injury: a bioinformatics and biological validation study.

Liu Y, Sheng X, Zhao Z, Li H, Lu J, Xie L Hereditas. 2025; 162(1):35.

PMID: 40069854 PMC: 11895329. DOI: 10.1186/s41065-025-00397-5.


In silico pentapeptide design for the inhibition between S100 calcium-binding A9 (S100A9) proteins.

Pan J, Ng C, Lim T, Choong Y J Mol Model. 2025; 31(3):77.

PMID: 39920469 DOI: 10.1007/s00894-025-06298-8.


Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.

Tan S, Tang H, Zhang Z, Wang Y, Li H, Shi W Clin Med Insights Oncol. 2024; 18:11795549241239042.

PMID: 38510315 PMC: 10952989. DOI: 10.1177/11795549241239042.


Advances in the study of S100A9 in cardiovascular diseases.

Chen F, He Z, Wang C, Si J, Chen Z, Guo Y Cell Prolif. 2024; 57(8):e13636.

PMID: 38504474 PMC: 11294427. DOI: 10.1111/cpr.13636.


RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.

Faruqui T, Khan M, Akhter Y, Khan S, Rafi Z, Saeed M Int J Mol Sci. 2023; 24(1).

PMID: 36613714 PMC: 9820344. DOI: 10.3390/ijms24010266.